Clinical & translational oncology

• 

  Año 2020, Vol. 22, Número 10

  • Review Article

    • Drug-metabolizing enzymes: role in drug resistance in cancer

      G. Kaur, S.K. Gupta, P. Singh, V. Ali, V. Kumar, M. Verma

      • Resumen

      págs. 1667-1680

      

    • Chemo-radiotherapy integration in unresectable locally advanced non-small-cell lung cancer:: a review

      E. Baldini, C. Tibaldi, C. Delli Paoli

      • Resumen

      págs. 1681-1686

      

    • Current updates on the role of reactive oxygen species in bladder cancer pathogenesis and therapeutics

      D. Liu, Feng Pan

      • Resumen

      págs. 1687-1697

      

    • Challenges in the treatment of breast cancer brain metastases:: evidence, unresolved questions, and a practical algorithm

      I. Meattini, Nicolaus H. Andratschke, A.M. Kirby, G. Sviri, B.V. Offersen, P. Poortmans, Orit Kaidar-Person

      • Resumen

      págs. 1698-1709

      

  • Special Article

    • Exercise and cancer:: a position statement from the Spanish Society of Medical Oncology

      Marina Pollán Santamaría, S. Casla Barrio, J. Alfaro Lizaso, Emilio Esteban González, Miguel Ángel Seguí Palmer, Alejandro Lucía Mulas, Miguel Martín Jiménez

      • Resumen

      págs. 1710-1729

      

  • Research Article

    • THBS1 facilitates colorectal liver metastasis through enhancing epithelial–mesenchymal transition

      X. Liu, D. Xu, Z. Liu, Y Li, C. Zhang, Y. Gong, Y. Jiang, B. Xing

      • Resumen

      págs. 1730-1740

      

    • Effects of different doses of propofol on the growth and expression of PCNA, CD34 and pAKT proteins in xenografted tumor of BALB/C mice with liver cancer

      H. Wu, Q. Zhou, Y. Liu, N. Zhang, H. Liang, M. Gu, H. Liu, H. Wang

      • Resumen

      págs. 1741-1749

      

    • The efficacy and safety of immunotherapy targeting the PD-1 pathway for advanced urothelial carcinoma:: a meta-analysis of published clinical trials

      F. Zhang, Z. Liu, J. Liang, F. Zhang, K. Wu, C.-C. Zhou, Y. Lu, X. Wang

      • Resumen

      págs. 1750-1761

      

    • RUNX1-activated upregulation of lncRNA RNCR3 promotes cell proliferation, invasion, and suppresses apoptosis in colorectal cancer via miR-1301-3p/AKT1 axis in vitro and in vivo

      H. Wang, G. Xu, D. Yuan, J. Yao, L. Meng, K. Li, Y. Zhang, C. Dang, K. Zhu

      • Resumen

      págs. 1762-1777

      

    • Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice

      J. Jiménez Castro, Elisabeth Pérez Ruiz, Miguel Ángel Berciano Guerrero, J. Valdivia Martín, S. Estalella Mendoza, F. Toscano, M. Rodríguez de la Borbolla Artacho, Margarita Garrido Siles, M. J. Martínez Bautista, R.M. Villatoro Roldán, Francisco Rivas Ruiz, E. Nogales Fernández, Rafael Morales Chamorro, B. Pérez Valderrama, Luis de la Cruz-Merino, Antonio Rueda Domínguez

      • Resumen

      págs. 1778-1785

      

    • Long noncoding RNA SNHG12 suppresses esophageal squamous cell carcinoma progression through competing endogenous RNA networks

      M. Liang, Z. Pan, C. Chen, F. Yu

      • Resumen

      págs. 1786-1795

      

  • Correspondence

    • Malignancies after renal transplantation:: experience of a Mexican referral center

      Eucario León-Rodríguez, A. Armengol Alonso, Mónica M. Rivera Franco, Josefina Alberú Gómez, P. Merchan Alvear

      • Resumen

      págs. 1796-1801

      

  • Research Article

    • VMAT partial-breast irradiation: acute toxicity of hypofractionated schedules of 30 Gy in five daily fractions

      E. La Rocca, L. Lozza, M. Dispinzieri, C. Giandini, F. Bonfantini, R. Valdagni, S. Folli, E. Pignoli, S. Di Cosimo, M. C. De Santis

      • Resumen

      págs. 1802-1808

      

    • Brain metastases treated with radiosurgery or hypofractionated stereotactic radiotherapy:: outcomes and predictors of survival

      María Isabel García Berrocal, M. Sallabanda, J. Romero, A. Garcia, M.J. Expósito, D.F. Rincón, Irma Zapata Paz, M.R. Magallón

      • Resumen

      págs. 1809-1817

      

    • Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors

      E. Cocorocchio, C. Martinoli, S. Gandini, L. Pala, F. Conforti, S. Stucchi, G. Mazzarol, P. Ferrucci

      • Resumen

      págs. 1818-1824

      

    • The risk of malignancies in patients receiving hematopoietic stem cell transplantation:: a systematic review and meta-analysis

      K. Heydari, A. Shamshirian, P. Lotfi Foroushani, A. Aref, A. Hedayatizadeh Omran, M. Ahmadi, G. Janbabei, S. Keyhanian, E. Zaboli, S.M. Ghasemzadeh

      • Resumen

      págs. 1825-1837

      

    • PRDX2 plays an oncogenic role in esophageal squamous cell carcinoma via Wnt/β-catenin and AKT pathways

      A. L. Feng, X. Han, X. Meng, Z. Chen, Q. Li, W. Shu, H. Dai, J. Zhu

      • Resumen

      págs. 1838-1848

      

    • Prognostic value of neutrophil-to-lymphocyte ratio and other inflammatory markers in patients with high-risk soft tissue sarcomas

      David Viñal, A. Redondo Sánchez, D. Martinez, J.A. Garcia Cuesta, L. Gutierrez Sainz, S. Martinez Recio, J. Villamayor, Virginia Martínez Marín, A. Gallego, Eduardo J. Ortiz Cruz, M. Mendiola, José Juan Pozo Kreilinger, A. Berjón, B. Belinchon, D. Bernabeu, E. Espinosa Arranz, Jaime Feliu Batlle

      • Resumen

      págs. 1849-1856

      

    • Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer:: incidence and time course of adverse events in the phase IIIb BALLET population

      G. Jerusalem, E. Ciruelos, Miguel Martín Jiménez, V.C.G. Tjan Heijnen, P. Neven, Joaquín Gavilá Gregori, F. Montemurro, D. Generali, I. Lang, M.J. Martínez Serrano, María F. Perelló, P. Conte

      • Resumen

      págs. 1857-1866

      

    • Expression-based, consistent biomarkers for prognosis and diagnosis in lung cancer

      Macarena Arroyo Varela, Rafael Larrosa Jiménez, Josefa Gómez Maldonado, Manuel Cobo Dols, Manuel Gonzalo Claros Díaz, Rocío Bautista Moreno

      • Resumen

      págs. 1867-1874

      

    • Multifunctional nanocomposites MGO/FU-MI inhibit the proliferation of tumor cells and enhance the effect of chemoradiotherapy in vivo and in vitro

      X. Peng, C. Yang, X. Kong, Y. Xiang, W. Dai, H. Quan

      • Resumen

      págs. 1875-1884

      

    • Subtype-specific risk factors for postmenopausal breast cancer:: findings from the PLCO trial

      P.A. Tang, O. Abdel Rahman, W.Y. Cheung

      • Resumen

      págs. 1885-1891

      

    • Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer:: a meta-analysis including 5177 patients

      Z. Zhao, H. Mu, Y. Li, Y. Liu, J. Zou, Y. Zhu

      • Resumen

      págs. 1892-1906

      

    • Letter to Editor regarding “The risk of malignancies in patients receiving hematopoietic stem cell transplantation:: a systematic review and meta‑analysis

      F. Rezaeeniya

      págs. 1907-1908

      

  • Correspondence

    • Reply to: “The risk of malignancies in patients receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis”

      K. Heydari, A. Shamshirian, R. Alizadeh Navaei

      págs. 1908-1909